Barclays raised the firm’s price target on Morgan Stanley (MS) to $156 from $155 and keeps an Overweight rating on the shares. The bank’s Q4

Morgan Stanley topped by deal value with $96bn in deals while Stifel/KBW led by deal volume with 37 transactions.

Delving into the details, we found 50% of traders were bullish, while 50% showed bearish tendencies. Out of all the trades we spotted, 5 were puts, with a value of $368,287, and 3 were calls, valued at $221,926.

Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 23.59% of W R Berkley Corp (WRB)’s shares, while financial institutions hold 68.75%.

Barclays analyst Jason Goldberg maintained a Buy rating on Morgan Stanley (MS – Research Report) today and set a price target of $155.00. The

Whales with a lot of money to spend have taken a noticeably bearish stance on Morgan Stanley. If we consider the specifics of each trade, it is accurate to state that 12% of the investors opened trades with bullish expectations and 62% with bearish.

Morgan Stanley’s shares rose 1.2% in Monday’s pre-market session, tracking the broader market, just days ahead of its fourth-quarter earnings report. Wall Street expects the lender to report quarterly earnings per share of $1.

Morgan Stanley’s profit more than doubled in the fourth quarter, fueled by a wave of dealmaking and stock sales that drove its revenue to a full-year record. The earnings rounded out a robust ...

Databricks has confirmed that it has closed a previously announced $10 billion in Series J equity financing at a $62 billion valuation.

Databricks, the Data and AI company, today announced the final closing of its Series J funding. Existing investor QIA, the sovereign wealth fund of the State of Qatar, along with new investors including Temasek and entities administered by Macquarie Capital,

Netflix, Inc. ($NFLX) analysts scrambled to raise their price targets for the stock following the streaming giant’s stellar quarterly results and price hike announcement. In premarket trading, the stock jumped nearly 15% to $998.

Elevance Health Inc (ELV) stock saw a modest uptick, ending the day at $385.29 which represents a slight increase of $0.03 or 0.01% from the prior close of $385.26. The stock opened at $387.02 and touched a low of $383.